These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2820197)

  • 1. Simultaneous central administration of adrenaline and neuropeptide Y leads to antagonistic interactions in vasodepressor responses in awake male rats.
    Härfstrand A; Fuxe K
    Acta Physiol Scand; 1987 Jul; 130(3):529-31. PubMed ID: 2820197
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in pituitary-adrenal activity regulate the central vasodepressor responses induced by neuropeptide Y and adrenaline in the awake unrestrained male rat.
    Aguirre JA; Fuxe K; Andbjer B; Eneroth P; Agnati LF
    Acta Physiol Scand; 1991 Jan; 141(1):35-44. PubMed ID: 2053445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centrally injected neuropeptide Y (13-36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1-36) in the awake male rat.
    Aguirre JA; Fuxe K; Agnati LF; von Euler G
    Neurosci Lett; 1990 Oct; 118(1):5-8. PubMed ID: 2259468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraventricular administration of neuropeptide Y (NPY) induces hypotension, bradycardia and bradypnoea in the awake unrestrained male rat. Counteraction by NPY-induced feeding behaviour.
    Härfstrand A
    Acta Physiol Scand; 1986 Sep; 128(1):121-3. PubMed ID: 3766169
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence that intracisternal injections of cholecystokinin-8 counteracts the cardiovascular effects of intracisternally injected adrenaline and neuropeptide Y in the alpha-chloralose anaesthetized rat.
    Härfstrand A; Fuxe K; Agnati LF
    J Hypertens Suppl; 1986 Dec; 4(6):S251-3. PubMed ID: 3475413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased vasopressor potency of the centrally injected neuropeptide Y fragment 13-36 in the adult spontaneously hypertensive awake male rat of the Wistar-Kyoto strain.
    Aguirre JA; Fuxe K; Agnati LF
    Acta Physiol Scand; 1990 Aug; 139(4):609-10. PubMed ID: 2248040
    [No Abstract]   [Full Text] [Related]  

  • 7. Central catecholamine-neuropeptide Y interactions at the pre- and postsynaptic level in cardiovascular centers.
    Fuxe K; Härfstrand A; Agnati LF; Kalia M; Fredholm B; Svensson T; Gustafsson JA; Lang R; Ganten D
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S1-13. PubMed ID: 2455156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of intracerebral injection of neuropeptide Y in rats.
    Yang SN; Yang W; Tang YH; Wang S
    Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):116-8. PubMed ID: 1598826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-injections of neuropeptide Y with adrenaline or noradrenaline induces contrasting cardiovascular responses in conscious rats.
    Gradin K
    Acta Physiol Scand; 1997 Sep; 161(1):121-2. PubMed ID: 9381944
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiovascular effects of microinjection of neuropeptide Y into lateral septal nucleus].
    Yang SN; Wang S; Tang YH
    Sheng Li Xue Bao; 1992 Aug; 44(4):401-4. PubMed ID: 1293754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin-releasing peptide effects in the rat brain are mediated through the Neuropeptide FF receptor.
    Ma L; MacTavish D; Simonin F; Bourguignon JJ; Watanabe T; Jhamandas JH
    Eur J Neurosci; 2009 Oct; 30(8):1585-93. PubMed ID: 19821834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of pentagastrin with intracerebroventricular injection on blood pressure and heart rate in rats].
    Wang MJ; Huang CJ; Zhang GS
    Sheng Li Xue Bao; 1995 Jun; 47(3):297-300. PubMed ID: 7570118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic exposure to neuropeptide Y determines cardiac alpha 1-adrenergic responsiveness.
    Sun LS; Ursell PC; Robinson RB
    Am J Physiol; 1991 Sep; 261(3 Pt 2):H969-73. PubMed ID: 1679606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of neuropeptide Y (NPY) in cardiovascular responses to stress.
    Zukowska-Grojec Z; Vaz AC
    Synapse; 1988; 2(3):293-8. PubMed ID: 3212674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.
    Armstrong JM; Lefèvre-Borg F; Scatton B; Cavero I
    J Pharmacol Exp Ther; 1982 Nov; 223(2):524-35. PubMed ID: 6127404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem.
    Grundemar L; Wahlestedt C; Reis DJ
    J Pharmacol Exp Ther; 1991 Aug; 258(2):633-8. PubMed ID: 1678015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central and peripheral effects of sculpin pancreatic polypeptide and anglerfish peptide Y in rats.
    Balasubramaniam A; Rigel DF; Chance WT; Fischer JE
    Pept Res; 1992; 5(2):106-9. PubMed ID: 1581637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat.
    Fuxe K; Agnati LF; Härfstrand A; Zini I; Tatemoto K; Pich EM; Hökfelt T; Mutt V; Terenius L
    Acta Physiol Scand; 1983 Jun; 118(2):189-92. PubMed ID: 6137937
    [No Abstract]   [Full Text] [Related]  

  • 19. The Y1 receptor subtype mediates the cardiovascular changes evoked by NPY administered into the posterior hypothalamic nucleus of conscious rat.
    Martin JR
    Brain Res; 2004 Mar; 1002(1-2):11-20. PubMed ID: 14988028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central and peripheral cardiovascular effects of alpha-methylepinephrine.
    Tung CS; Goldberg MR; Hollister AS; Oates JA; Robertson D
    J Pharmacol Exp Ther; 1983 Nov; 227(2):484-90. PubMed ID: 6355433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.